
The companies will develop and commercialise therapies for genetic conditions

The programme is designed to reduce the review time for companies supporting US national interests
By Sarah Mohamad and Lauren Coleman-Bennett
By Sam Fraser

Approximately 7,700 people in England are living with the genetic bleeding disorder

The mosquito-borne viral disease has been reported across many popular travel destinations

The factor VIII replacement therapy has been authorised to treat and prevent bleeding in children and adults

The progressive neuromuscular disease affects approximately one in every 10,000 babies globally

The genetic bleeding disorder affects an estimated one per every 19,283 male births in the US

The inherited bleeding disorder accounts for up to 85% of the 1,125,000 global haemophilia cases

About 15,000 people in England are living with the inherited blood disorder

The company hopes the revised protocol will accelerate the development timeline of buntanetap